Expansinvest
14
1M
14
1
2
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Corenc. The company was established in Europe in France.
Speaking about the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2019. Comparing to the other companies, this Expansinvest performs on 14 percentage points less the average number of lead investments. The important activity for fund was in 2015.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline BiBOARD, SynapCell, NightSwapping Among the most popular fund investment industries, there are Pharmaceutical, Computer. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. The fund has specific favorite in a number of founders of portfolio startups.
The overall number of key employees were 4.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Expansinvest, startups are often financed by Axeleo. The meaningful sponsors for the fund in investment in the same round are Rhone-Alpes Creation, Groupe Siparex, Bpifrance. In the next rounds fund is usually obtained by KREAXI, Sofimac Partners, Sigma Investment Counselors.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 1
- Exits
- 2
- Investments by industry
- Software (4)
- Industrial Engineering (2)
- Computer (2)
- Manufacturing (2)
- Information Technology (2) Show 25 more
- Investments by region
-
- France (14)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 0.71
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
SynapCell | 06 Mar 2009 | Biotechnology, Pharmaceutical, Therapeutics, Clinical Trials | Early Stage Venture | 4M | Rhone-Alpes, Grenoble, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.